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Summary
Objective: The cryopreservation of intact articular cartilage is constrained by minimal chondrocyte survival. It was the aim of the present study
to gain an insight into the permeation kinetics of cryoprotectants through cartilage. This knowledge is essential for achieving adequate tissue
permeation prior to cooling.
Design: The diffusion coefﬁcients and penetration rates through human articular cartilage of dimethyl sulfoxide (Me2SO) and glycerol at
different temperatures (4(C, 17(C, 27(C and 37(C) and at two concentrations [10% (v/v) and absolute state] were measured using diffusion
nuclear magnetic imaging. Deuterated water (D2O) was used as a control substance.
Results: Glycerol penetrated faster than Me2SO at all temperatures and at rates that were comparable to those for D2O. The penetration rate
of each agent increased with increasing temperature. The diffusion coefﬁcients for glycerol and Me2SO increased with increasing temperature
and decreased at the higher concentration, but the differences between each agent were not signiﬁcant.
Conclusions: The classical cryopreservation protocols expose cartilage samples toMe2SOat a too low temperatureand/or for an insufﬁcient time
period for optimal cell survival. When considering the penetration rate, glycerol appears to be a more efﬁcient cryoprotective agent than Me2SO.
The present study demonstrates the power of nuclear magnetic resonance technology to elucidate key physiological factors in cryobiology.
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Cartilage
Repair
SocietyIntroduction
The use of osteochondral allografts to replace damaged or
diseased joint tissue has become commonplace. The
variable graft failure rate, which ranges between 10% and
50%1e5, may partially reﬂect the state of the tissue ( fresh vs
frozen) and the speciﬁc clinical circumstances. The clinical
success that has been achieved by ﬁlling full-thickness
articular cartilage defects with fresh osteochondral shell
allografts6e8 is limited by the shortage of supplies and by
the potential risk of transmitting viral diseases. The limited
supplies of fresh graft tissue necessitate the long-term
storage of osteochondral allograft. So for cryopreservation
to qualify as a feasible banking method, the articular
chondrocytes should survive their exposure to ultra-low
temperatures. The use of cryoprotective agents is one
means of preserving the viability of articular cartilage
chondrocytes upon which the success of transplantation
depends. The cryoprotective agents most commonly used
in orthopedics are dimethyl sulfoxide (Me2SO) and glycerol.
These substances belong to the family of penetrating
cryoprotective agents that can protect the tissue from
freezing damage only if they penetrate all of the constituent
cells. It is well known that isolated chondrocytes survive
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Received 24 June 2003; revision accepted 18 June 2004.787freezing in the presence of cryoprotective agents9e12
whereas in situ they succumb and exhibit viabilities ranging
from 0% to 75%11,13e17. This circumstance suggests that
the cartilage matrix prevents the protective agent from
reaching all of the cells. This postulate is supported by the
ﬁnding that chondrocyte survival after cryopreservation is
conﬁned largely to the superﬁcial layer of the cartilage
matrix15,18.
A knowledge of the permeation kinetics of cryoprotec-
tants through intact cartilage is essential for controlling the
osmotic and chemical activity of the tissue and achieving its
adequate permeation prior to cooling. One of the difﬁculties
encountered in the study of cryopreservation is that no
technique exists whereby the distribution and concentration
of cryoprotective agents can be monitored throughout
a tissue sample during the equilibration period. The
techniques employed to obtain information about the
penetration rates of cryoprotective agents in tissue samples
are varied and include chemical methods19, the use of
radiotracers20,21, and nuclear magnetic resonance (NMR)
spectroscopy22,23.
NMR techniques can be used to measure the diffusivity of
any NMR-observable nucleus non-invasively, and they are
thus applicable in vivo. The penetration rate of a cryopro-
tectant is evaluated by analyzing the changes in image
intensity relative to the exposure time of the tissue to the
agent24. Using human articular cartilage as a model, it is the
purpose of the present study to determine the diffusion
coefﬁcients of Me2SO and glycerol and their rate of
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concentrations.
Method
CRYOPROTECTIVE AGENTS
The cryoprotective agents studied were Me2SO
(C2H6OS; Sigma Chemical Company, St. Louis, MO) and
glycerol (C3H8O3; Merck, Darmstadt, Germany). They were
tested at the usual working concentration of 10% (v/v) and
in the absolute state (100% for Me2SO and 90% for
glycerol, which exists as a solid at higher concentrations).
Deuterated water (D2O; SDS, Peypin, France), whose
interactions with the cartilage matrix should not differ from
those of water, was included as a control substance.
ORIGIN AND PROCESSING OF THE SAMPLES
Samples of human articular cartilage were obtained from
multiorgan donors (!40 years of age), post-mortem, and
from elderly patients (O65 years of age) undergoing
hemiarthroplasty for fractures of the femoral neck. In young
donors, the cartilage samples (NZ 28) were harvested
from the patellar surface of the knee joint 4e24 h post-
mortem. In elderly patients, the cartilage samples (NZ 57)
were obtained from the central portion of the femoral head,
around the ligamentum teres.
The articular cartilage samples were shaved into full-
thickness fragments (1 cm! 3 cm) using a sharp knife and
preserved in saline at 4(C. The thickness of the cartilage
layer averaged 2.2G 0.5 mm for the femoral heads (elderly
patients) and 3.4G 0.6 mm for the patellar surfaces ( young
donors). To facilitate harvesting and handling, we worked
with denuded cartilage. Xia et al.25 have shown that excised
discs of cartilage serve as excellent models for diffusion
experiments, exhibiting characteristics that are virtually
identical to those manifested by boneecartilage plugs.
IMAGE ACQUISITION
The studies were performed using a 4.7 Bruker 47/40
Biospec spectrometer (Bruker Medizintechnik GmBH, Et-
tlingen, Germany) equipped with a volume coil 7 cm in
diameter. After running scout scans to locate the position of
the cartilage specimen in the perfusion chamber, images
were acquired with a ﬁeld of view 4.1 cm in diameter. The
matrix size (256! 256) permits a pixel resolution of
100 mm and a slice thickness of 3 mm. T2-weighted images
were obtained with a fast-spin echo-pulse sequence with
a repetition time (TR) of 3098 ms, echo time (TE) of 13 ms,
and an echo train length factor of eight. Self-developed
software on IDL (Interactive Data Language, Research
Systems, Boulder, CO), running on a Sun Sparc 10
workstation, was used to visualize the images, to select
the regions of interest on each image, and for data
analysis.
IMAGE PROCESSING
Determination of the half-penetration time (t1/2)
To evaluate the permeation kinetics of the cryoprotective
agents, a customized temperature-controlled perfusion
system was designed and built in our laboratory (Fig. 1).
The system includes a jacketed chromatograph column
(Pharmacia, Uppsala, Sweden), through which ﬂuidcourses from a heated circulator bath under thermostatic
control (Haake D8-G, Karlsruhe, Germany). The tempera-
ture of each specimen was continuously monitored by
means of a thermal probe attached to its periphery.
Cryoprotective media were rapidly exchanged with the aid
of a peristaltic pump (Eyela MP-3, Tokio Rikakikai Co.,
Tokio). A small tube ﬁlled with saline (saline reference in
Fig. 1) was introduced as an internal control of the signal
intensity in each experiment. The ﬂuid circulating through
the jacket of the column contained copper sulfate as a
paramagnetic agent to minimize signal intensity and pos-
sible artifacts arising from the water. The relative image
intensities (Icartilage/I0) were calculated using the value
measured in the cartilage sample before exchanging the
medium (I0). Figure 2 depicts the typical mono-exponential
behavior obtained. This is common for transport phenom-
ena and is described by the equation
I ¼ ACB!ekt
A and B are determined by the initial and ﬁnal conditions of
the experiment and k is a measurement of the rate of the
change in intensity (related to the penetration of the
cryoprotective agent). The half-penetration time (t1/2) is
the time needed for 50% of the changes to occur and can
be calculated as 0.69/k. This time is inversely proportional
to the cartilage matrix permeability for each agent.
Permeability is the term that describes the passage of
molecules across barriers and is applied to the diffusion of
particles through membranes. The estimated values should
be considered as the lowest limit for any actual cryopro-
tection procedure.
The experiments were performed in triplicate for glycerol
and Me2SO at the different concentrations and temper-
atures (4(C, 7(C, 27(C, 37(C). Those involving 90%
New media input
Thermal probe
Old media output 
Thermometer
Bath H2O + CuSO4
cartilage
Saline reference
Fig. 1. Customized temperature-controlled perfusion system in-
cluding a jacketed chromatograph column through which ﬂuid
courses from a heated circulator bath. Sample temperature is
monitored by means of a thermal probe. Cryoprotective media are
rapidly exchanged with the aid of a peristaltic pump. A small tube
ﬁlled with saline (saline reference) is introduced as an internal
control of the signal intensity. The ﬂuid circulating through the jacket
of the column contains copper sulfate as a paramagnetic agent to
minimize signal intensity and possible artifacts arising from the
water.
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viscosity, and they were performed only at 4(C.
Diffusion maps
Additional NMR diffusion-weighted acquisitions were
obtained when the specimen was completely equilibrated
under the ﬁnal conditions in order to estimate the apparent
diffusion coefﬁcient (D). Assuming that the nuclei are
moving with free Brownian motion described by a single
diffusion constant, it has been shown that the ratio R of the
NMR signal, with a pair of diffusion-sensitizing magnetic
ﬁeld gradients in a standard spin echo sequence which is
obtained without ﬁeld gradients, can be written as26:
lnðRÞ ¼ g2g2d2ðD d=3ÞD
Here d is the duration of each gradient pulse and D is the
time interval separating their onset. g is the applied gradient
intensity and g is the gyromagnetic ratio of the observed
nucleus (1H in our case). The experiment is typically
performed such that R is measured for different values of
g (5, 15, 30 and 40 mT/cm) with all other variables being
constant. D is subsequently calculated by ﬁtting the data on
a pixel-by-pixel basis, to the given equation. The resulting
images are called diffusion maps. The data are given as
meansGSD in the region of interest (cartilage and external
medium).
STATISTICS
The ﬁnal data for t1/2 and D for the different agents and
temperatures were compared by means of Student’s t-test
and analysis of variance (ANOVA) using SPSS for Win-
dows (version 10.0). Differences were considered to be
statistically signiﬁcant if the P-value was !0.05. Graphics
were generated using Prism version 3 for Windows.
Results
The penetration rates of Me2SO and glycerol through
specimens of human articular cartilage were determined as
a function of temperature (4(C, 17(C, 27(C, 37(C) using
T = 4°C
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Fig. 2. Cartilage signal intensity (Icartilage) in the presence of 10%
Me2SO at 4(C (TZ 4(C), normalized to that of the saline
reference (I0), and expressed as a function of time. A statistically
signiﬁcant one phase exponential decay model has been ﬁtted to
the data (P! 0.001, R2Z 0.99).two different concentrations. Both cryoprotective agents
were tested at a working concentration of 10% and in an
absolute state, i.e., 100% for Me2SO and 90% for glycerol.
Owing to viscosity problems, data pertaining to 90%
glycerol were available only at 4(C. Each experiment was
performed in triplicate. The results (expressed as mean
valuesG S.E.M.) are represented graphically in Fig. 3 and
the salient features of the t1/2 (half-penetration time)
analysis are summarized in Table I. Post hoc tests revealed
signiﬁcant differences between the control (D2O) and
Me2SO, and between Me2SO and glycerol, but not between
glycerol and the control. The differences between mean t1/2
values obtained at 4(C and 37(C were also signiﬁcant.
A change in concentration did not signiﬁcantly affect the
penetration rate of Me2SO (PZ 0.316). But at 4(C, 90%
glycerol penetrated the tissue at a signiﬁcantly slower rate
than did 10% glycerol (PZ 0.006).
Once the cartilage specimen was fully equilibrated with its
bathing medium, images with different gradients e so called
diffusion maps e were obtained (Fig. 4). The diffusion
coefﬁcients (D) calculated from these diffusion maps are
represented in Table II. D increased with increasing
temperature and decreased with increase in agent concen-
tration. The statistical analysis revealed differences to be
signiﬁcant for both temperature (PZ 0.043) and concen-
tration (PZ 0.015), but to be non-signiﬁcant between the
two cryoprotective agents. When data pertaining to the
diffusivity of an agent through cartilage (D) were expressed
relative to the agent’s diffusivity in free solution (D0), the
concentration dependency of D remained signiﬁcant
(PZ 0.003).
Discussion
Endeavors to improve the rate of chondrocyte survival
within cryopreserved articular cartilage should aim to
optimize each parameter relating to the freezing procedure.
Amongst the relevant considerations, a thorough penetra-
tion of the cryoprotectant through the intact sample is
essential for a successful outcome.
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Fig. 3. Graphic representation of the t1/2 values for each
cryoprotectant and for D2O (control) at different temperatures and
concentrations. The half-penetration time (t1/2) is the time required
for 50% of the changes to occur and is calculated as 0.69/k. This
time is inversely proportional to the permeability of the cartilage
matrix to each agent. The estimated values should be considered
as the lowest limit for any actual cryoprotection procedure. Data are
expressed as mean valuesG S.E.M. The isolated data point at 4(C
is for 90% glycerol. d, D2O; -  -  -  -, 10% glycerol; - - - - -, 10%
Me2SO;     , 100% Me2SO.
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sheep16, rabbit27 and pig28 cartilage, which have ignored
possibly signiﬁcant species differences in the tissue’s
response to the cryoprotectant. Muldrew et al.29 have
indeed encountered signiﬁcant differences in cartilage
cryoinjury even between various breeds of sheep. And
using the cornea as a model, differences in the tissue’s
susceptibility to toxic injury by Me2SO have been observed
between rabbits and pigs23. Human articular cartilage has
rarely been used as a model in cryopreservation studies.
But recently, Jomha et al.30,31 have pointed out the inherent
difﬁculty of obtaining viable chondrocytes after cryopreserv-
ing human and porcine cartilage according to the same
protocol that yielded moderate success with ovine cartilage
(50e60%16).
In the present study, we used NMR to evaluate the
permeation of two cryoprotective agents (Me2SO and
glycerol) through samples of human articular cartilage.
Although our material was derived from two distinct groups
of donors, it was used indistinguishably, since a comparison
Table I
Summary of the t1/2 analysis. The values obtained using the
different concentrations of each cryoprotectant (10% and 100%)
were compared by means of the t-test and those yielded at different
temperatures (4(C, 17(C, 27(C and 37 (C) by ANOVA. Differ-
ences were considered to be significant if the P-value was !0.05
t1/2 Concentration Temperature
D2O N/A 0.009
Me2SO 0.316 0.02
Glycerol 0.001 !0.001
N/A: not applicable.
Fig. 4. Diffusion map for 10% glycerol at 17(C. A diffusion map is
a parametric image containing the combined data of at least two
diffusion-weighted images which are differently sensitized to
diffusion but are identical with respect to other parameters. The
intensity of each pixel represents the mean intensity of the weighted
images thereby yielding the diffusion coefﬁcient (D). C: cartilage;
S: saline reference.between the categories lay beyond the scope of the
investigation.
Most of the common procedures used to assess the
penetration rates of cryoprotective agents through tissue
samples necessitate their destruction. These include the
measurement of changes in apparent tissue weight19, the
monitoring of osmotically induced changes in cell vol-
ume22,32 and the uptake of radioactive tracers20. In
contrast, NMR is a non-invasive and non-destructive
technique. Hence, consecutive measurements can be
made on a given sample without jeopardizing its utility for
clinical purposes. NMR uses non-ionizing radiation and
furnishes information regarding the molecular dynamics of
a number of physiologically relevant nuclei. NMR measure-
ments of diffusion can be made on a localized basis and
presented as an image, the intensity of which is proportional
to the diffusivity of the solutes within it.
Cryoprotective agents permeate isolated cells relatively
quickly but diffuse through multicellular tissue systems
more slowly, especially in the presence of a dense stroma.
Hence, exposure to the cryoprotectant may need to be
prolonged to attain adequate concentrations in the center of
the tissue, with the consequence that cells near the surface
are at risk of encountering toxic doses33. It is thus important
to balance equilibrium time against the harmful effects of
over-exposure2.
The rate of penetration of Me2SO through mammalian
tissue has been estimated by NMR to lie in the approximate
range of 2! 105 cm/s to 3! 105 cm/s at around
ambient temperature13. The rate of penetration of glycerol
through porcine dermis at 33(C falls within a similar range,
namely 1.89! 105 cm/s to 2.96! 105 cm/s34. These
values indicate that the diffusion of cryoprotective agents
through intact tissues is fairly slow. Since optimal cryo-
preservation can be achieved only if the cryoprotective
agents permeate all of the constituent cells of a tissue,
a knowledge of these penetration rates is necessary to
adjust the protocols accordingly.
The rate of penetration of both Me2SO and glycerol
through human articular cartilage samples, as monitored
by changes in NMR image intensity, was characterized by
an initial period of rapid diffusion followed by a second
slower phase (Fig. 2). But the analyses revealed concen-
tration- and temperature-dependent differences between
the agents. The permeability of human articular cartilage to
each cryoprotectant clearly decreased at lower temper-
atures and was much higher for glycerol than for Me2SO,
the magnitude of this difference being greater at lower than
at higher temperatures (Fig. 3). At 4(C, t1/2 for glycerol
was half that for Me2SO. That the results for 10% glycerol
and D2O (control) were similar also points to glycerol as
being a more rapidly penetrating agent. The slower rate of
penetration of Me2SO through human articular cartilage
cannot be explained solely on the basis of differences in
the self-diffusion coefﬁcients or in molecular weight, which
are not great (78 g/mol and 98 g/mol for Me2SO and
glycerol, respectively). Differences in the penetration rates
of Me2SO and glycerol probably relate to the nature of
their interaction with the cartilage matrix. After collagenase
digestion of the cartilage matrix35e37, the diffusion of
Me2SO has been shown to be less impeded, indicating
that the collagenous network is responsible for the
restricted penetration. The distribution of cryoprotectants
within the tissue destined for freezing has also been
enhanced by effecting changes in its structural conﬁgura-
tion. Johma et al.31 achieved an improvement in chon-
drocyte viability by drilling 2-mm-diameter holes through
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Diffusion coefficients (D) for each of the tested agents and their diffusivities through cartilage expressed relative to their diffusivities in free
solution (D/D0). The ratio D/D0 yields information regarding tissue swelling
CPA D (!109 m2/s) D/D0
4(C 17(C 27(C 37(C 4(C 17(C 27(C 37(C
D2O 1.01 1.34 1.91 2.36 0.63 0.60 0.62 0.63
Me2SO 100% 0.31 0.62 0.68 0.72 0.81 0.86 0.89 0.76
Me2SO 10% 0.61 1.07 1.44 1.79 0.51 0.59 0.63 0.63
GLY 90% 0.96 1.00 1.06 1.15 0.89 0.84 0.79 0.51
GLY 10% 0.77 1.19 1.35 2.02 0.66 0.64 0.61 0.70
CPA: cryoprotective agents; GLY: glycerol.the subchondral bone of 10-mm-diameter osteochondral
plugs.
In many of the classical cryopreservation protocols,
cartilage samples are exposed to Me2SO at concentrations
varying between 7.5% and 10% for time periods ranging
from 30 min to 60 min at 4(C2,15,16,38. Exposure to the
cryoprotectant is undertaken at 4(C in order to reduce toxic
effects. However, the t1/2 values obtained in the present
study indicate that at this temperature, 10% Me2SO
penetrates the cartilage tissue samples to an insufﬁcient
degree. Recently, an alternative cryopreservation protocol
has been tested. This involved exposing ovine cartilage to
0.5 M propylene glycol for 60 min at 22(C14,39. Using this
strategy, the authors achieved a substantial improvement in
the recovery rate of ovine chondrocytes.
In previous studies, the diffusivity of small solutes (with
molecular weights less that 200) in healthy articular
cartilage has been shown to be 45e60% of that of the
same molecule in aqueous solution35,37,40,41. At ambient
temperature, the self-diffusion coefﬁcient of water mole-
cules in cartilage is 1.4! 109 m2/s, compared to
2.2! 109 m2/s to 3.2! 109 m2/s in water35,40. The
diffusion coefﬁcients obtained for Me2SO, glycerol and
D2O in the present study by NMR (Table II) accord with the
values yielded by other methods. A previous 1H-NMR
study42 has reported a diffusion coefﬁcient of
1.12! 109 m2/s for Me2SO through cartilage at ambient
temperature, which corresponds with our own determina-
tion. Our NMR data pertaining to the diffusion coefﬁcients
for glycerol through cartilage are new. The diffusion
coefﬁcients for both Me2SO and glycerol decreased with
an increase in concentration, which is consistent with
existing data. When the diffusivity of a particular substance
through cartilage (diffusion coefﬁcient) was expressed
relative to its diffusivity in free solution, the ratio thereby
yielded (D/D0) was approximately 0.6 for D2O (control) and
for each cryoprotective agent at a concentration of 10%.
The ratio increased when the agent’s concentration was
raised. The ratio D/D0 is linked to the water content of
cartilage36,43, which is strongly inﬂuenced by the tissue’s
osmotic pressure. And the osmotic pressure depends, in
turn, upon the molar concentration of the solutes at a given
temperature.
In conclusion, to be effective in the cryopreservation of
human articular cartilage, protocols utilizing Me2SO should
be modiﬁed by increasing either the exposure time to the
agent or the temperature during the pre-cooling stage. An
increase in the concentration of this cryoprotectant does not
result in a more rapid equilibrium, even though its level in
the sample may be higher. Cartilage appears to be more
permeable to glycerol than to Me2SO. But both agents
exhibit similar diffusion coefﬁcients, which increase withincreasing temperature and decrease with increase in
concentration.
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